Status:
COMPLETED
Engaging Sexual and Gender Minority Cigarette Smokers Into Social Media-based Treatment
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Tobacco Related Disease Research Program
Conditions:
Smoking Cessation
Nicotine Dependence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study will evaluate the preliminary efficacy of Pride Posts Plus, a social media-based smoking cessation treatment. A pilot randomized trial (N=120) will compare Pride Posts Plus, which ...
Detailed Description
Participants (N=136) will be randomized to one of three conditions: (1) Pride Posts, a Facebook-delivered smoking cessation intervention (including daily posts, and weekly live group sessions, tailore...
Eligibility Criteria
Inclusion
- Daily smoker
- Self-identify as sexual and/or gender minority
- Interested in quitting in next 6 months
- 6 months of Facebook experience
- English-speaking
Exclusion
- Contraindications to nicotine replacement therapy
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2022
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT04461288
Start Date
May 1 2020
End Date
May 30 2022
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143